Log in to save to my catalogue

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4cffeff90ca418b8ed9c213a7bf3531

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Antiangiogenic treatment targeting the vascular endothelial growth factor (VEGF) pathway is a powerful tool to combat tumor growth and progression; however, drug resistance frequently emerges. We identify CD5L (CD5 antigen-like precursor) as an important gene upregulated in response to antiangiogenic therapy leading to the emergence of adaptive res...

Alternative Titles

Full title

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a4cffeff90ca418b8ed9c213a7bf3531

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4cffeff90ca418b8ed9c213a7bf3531

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-36910-5

How to access this item